These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 18519766)

  • 21. Down-regulation of the antigen processing machinery is linked to a loss of inflammatory response in colorectal cancer.
    Kasajima A; Sers C; Sasano H; Jöhrens K; Stenzinger A; Noske A; Buckendahl AC; Darb-Esfahani S; Müller BM; Budczies J; Lehman A; Dietel M; Denkert C; Weichert W
    Hum Pathol; 2010 Dec; 41(12):1758-69. PubMed ID: 20869097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors.
    Cabrera CM; Jiménez P; Cabrera T; Esparza C; Ruiz-Cabello F; Garrido F
    Tissue Antigens; 2003 Mar; 61(3):211-9. PubMed ID: 12694570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of HLA-A02* genotype and HLA class I antigen down-regulation with the prognosis of epithelial ovarian cancer.
    Andersson E; Villabona L; Bergfeldt K; Carlson JW; Ferrone S; Kiessling R; Seliger B; Masucci GV
    Cancer Immunol Immunother; 2012 Aug; 61(8):1243-53. PubMed ID: 22258792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions.
    Vitale M; Rezzani R; Rodella L; Zauli G; Grigolato P; Cadei M; Hicklin DJ; Ferrone S
    Cancer Res; 1998 Feb; 58(4):737-42. PubMed ID: 9485029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker.
    Ogino T; Shigyo H; Ishii H; Katayama A; Miyokawa N; Harabuchi Y; Ferrone S
    Cancer Res; 2006 Sep; 66(18):9281-9. PubMed ID: 16982773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Markedly decreased expression of TAP1 and LMP2 genes in HLA class I-deficient human tumor cell lines.
    Singal DP; Ye M; Ni J; Snider DP
    Immunol Lett; 1996 May; 50(3):149-54. PubMed ID: 8803612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes.
    Leibowitz MS; Andrade Filho PA; Ferrone S; Ferris RL
    Cancer Immunol Immunother; 2011 Apr; 60(4):525-35. PubMed ID: 21207025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peptide-bound major histocompatibility complex class I molecules associate with tapasin before dissociation from transporter associated with antigen processing.
    Li S; Paulsson KM; Sjögren HO; Wang P
    J Biol Chem; 1999 Mar; 274(13):8649-54. PubMed ID: 10085102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional deficiencies of components of the MHC class I antigen pathway in human tumors of epithelial origin.
    Delp K; Momburg F; Hilmes C; Huber C; Seliger B
    Bone Marrow Transplant; 2000 May; 25 Suppl 2():S88-95. PubMed ID: 10933198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of HLA class I antigen-processing machinery components in esophageal squamous cell carcinomas: association with disease progression.
    Liu Q; Hao C; Su P; Shi J
    Scand J Gastroenterol; 2009; 44(8):960-9. PubMed ID: 19492245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defective HLA Class I Expression and Patterns of Lymphocyte Infiltration in Chordoma Tumors.
    Patel SS; Nota SP; Sabbatino F; Nielsen GP; Deshpande V; Wang X; Ferrone S; Schwab JH
    Clin Orthop Relat Res; 2021 Jun; 479(6):1373-1382. PubMed ID: 33273248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of peptide and major histocompatibility complex class I/beta 2-microglobulin binding to the transporters associated with antigen processing (TAP1 and TAP2).
    Androlewicz MJ; Ortmann B; van Endert PM; Spies T; Cresswell P
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12716-20. PubMed ID: 7809108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis.
    Kamarashev J; Ferrone S; Seifert B; Böni R; Nestle FO; Burg G; Dummer R
    Int J Cancer; 2001 Jan; 95(1):23-8. PubMed ID: 11241306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancer.
    Callahan MJ; Nagymanyoki Z; Bonome T; Johnson ME; Litkouhi B; Sullivan EH; Hirsch MS; Matulonis UA; Liu J; Birrer MJ; Berkowitz RS; Mok SC
    Clin Cancer Res; 2008 Dec; 14(23):7667-73. PubMed ID: 19047092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic changes within the promoter regions of antigen processing machinery family genes in Kazakh primary esophageal squamous cell carcinoma.
    Sheyhidin I; Hasim A; Zheng F; Ma H
    Asian Pac J Cancer Prev; 2014; 15(23):10299-306. PubMed ID: 25556465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma.
    Atkins D; Breuckmann A; Schmahl GE; Binner P; Ferrone S; Krummenauer F; Störkel S; Seliger B
    Int J Cancer; 2004 Mar; 109(2):265-73. PubMed ID: 14750179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of HLA class I, beta(2)-microglobulin, TAP1 and IL-10 in Epstein-Barr virus-associated nasal NK/T-cell lymphoma: Implications for tumor immune escape mechanism.
    Shen L; Chiang AK; Liu WP; Li GD; Liang RH; Srivastava G
    Int J Cancer; 2001 Jun; 92(5):692-6. PubMed ID: 11340574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Over-expressing transporters associated with antigen processing increases antitumor immunity response in prostate cancer.
    Qiu T; Wang L; Liu XH; Weng XD; Kuang YL; Chen ZY; Chen H; Zhu HC
    Cell Immunol; 2012 Oct; 279(2):167-73. PubMed ID: 23246678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In situ analysis of the antigen-processing machinery in acute myeloid leukaemic blasts by tissue microarray.
    Hoves S; Aigner M; Pfeiffer C; Laumer M; Obermann EC; Mackensen A
    Leukemia; 2009 May; 23(5):877-85. PubMed ID: 19148137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Major histocompatibility antigens and antigen-processing molecules in uveal melanoma.
    Krishnakumar S; Abhyankar D; Sundaram AL; Pushparaj V; Shanmugam MP; Biswas J
    Clin Cancer Res; 2003 Sep; 9(11):4159-64. PubMed ID: 14519640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.